Tutzauer, Julia http://orcid.org/0000-0001-8267-8445
Sjöström, Martin http://orcid.org/0000-0002-2629-9966
Holmberg, Erik http://orcid.org/0000-0001-5107-4550
Karlsson, Per http://orcid.org/0000-0003-4841-2672
Killander, Fredrika http://orcid.org/0000-0001-6266-0459
Leeb-Lundberg, L. M. Fredrik http://orcid.org/0000-0002-8583-2329
Malmström, Per
Niméus, Emma http://orcid.org/0000-0003-0262-9083
Fernö, Mårten
Jögi, Annika http://orcid.org/0000-0003-1697-8030
Article History
Received: 4 July 2021
Revised: 17 October 2021
Accepted: 3 November 2021
First Online: 9 February 2022
Ethics approval and consent to participate
: The trial and follow-up including tissue microarrays (TMAs) were conducted in accordance with the declaration of Helsinki and approved by the local ethics committees. Gene-expression analyses were approved by the Lund University Ethical Review Board (2010/127, 2015/548). Oral informed consent was obtained from all patients, which was approved by the Ethical Review Board for the original trial and for the gene-expression study.
: No individual person’s data is presented.
: The authors AJ, FK, EN, JT, LMFL-L and MS declare no competing interests. PK, EH, PM and MF research contract with PFS Genomics.